SPH

Shanghai Pharmaceuticals Holding Co., Ltd. (hereinafter referred to as "SPH" or "the Company") is a large pharmaceutical industry group listed in both Shanghai and Hong Kong (HKEX stock code: 02607; SSE stock code: 601607). The company's main business covers pharmaceuticals manufacturing and commerce, with revenue of 191.9 billion yuan in 2020. It ranks among the Fortune Global 500 and the top 50 global pharmaceutical companies, second in China’s pharmaceutical enterprises. It is included in the SSE 180 Index, CSI 300 Index constituent stocks, and the Morgan Stanley China Index (MSCI).SPH advocates the core corporate values of "innovation, integrity, cooperation, inclusiveness, and responsibility," and is committed to persistently improving people's health and quality of life. It strives to become a respected leading brand-name drug manufacturer and health service provider with an excellent reputation in the industry.